Bioimpedance in CKD: an untapped resource?

Mayne, K. J., Lees, J. S. and Herrington, W. G. (2023) Bioimpedance in CKD: an untapped resource? Nephrology Dialysis Transplantation, 38(3), pp. 583-585. (doi: 10.1093/ndt/gfac275) (PMID:36260361) (PMCID:PMC9976732)

[img] Text
282739.pdf - Published Version
Available under License Creative Commons Attribution.



No abstract available.

Item Type:Articles
Additional Information:Core funding is provided to Clinical Trial Service Unit by the UK Medical Research Council (MRC) (MC_UU_00017/3) and the British Heart Foundation. Outside the submitted work, K.J.M. and W.G.H. report funds from Boehringer Ingelheim and Eli Lilly paid to their institution, the University of Oxford. W.G.H. was funded by an MRC–Kidney Research UK Professor David Kerr Clinician Scientist Award (MR/R007764/1). J.S.L. was funded by a Chief Scientist Office Postdoctoral Lectureships Award (PCL/20/10). Outside the submitted work, J.S.L. has received lectureship honoraria from Pfizer, AstraZeneca and Bristol Myers Squibb.
Glasgow Author(s) Enlighten ID:Lees, Jennifer and Mayne, Dr Kaitlin and Herrington, Professor William
Authors: Mayne, K. J., Lees, J. S., and Herrington, W. G.
College/School:College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Nephrology Dialysis Transplantation
Publisher:Oxford University Press
ISSN (Online):1460-2385
Published Online:19 October 2022
Copyright Holders:Copyright © 2022 The Authors
First Published:First published in Nephrology Dialysis Transplantation 38(3): 583-585
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record